Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) fell 5% to $8.11 in pre-market trading. In December, the U.S. Food and Drug Administration (FDA) approved Vanda Pharmaceuticals' Nereus (tradipitant) to prevent vomiting induced by motion.

Scotiabank strategist Jean-Michel Gauthier made four changes to his quantitatively driven top 30 stock lists, adding Toronto-Dominion Bank ( TD-T +1.89% ) and Centerra Gold Inc. ( Split N/A N/A 12/29/21 N/A 12/29/21 N/A 1-2.5 ) and removing Celestica Inc. ( Split N/A N/A 12/29/21 N/A 12/29/21 N/A 1-2.5 ) and Empire Co. Ltd. ( VSP-T +0.66% ).

The numbers themselves are somewhat jaw dropping,” said IG Wealth Management chief investment strategist Philip Petursson by phone.

As we enter 2026, investors are encouraged to reassess the health of both the Canadian and U.S. economies, especially given recent fluctuations in employment trends and inflation data. In this context,

Shares S&P/TSX Capped Energy Index ETF (TSX:XEG) and Canadian crude have taken a hit to start the year, but it might be too soon to buy. The post Canadian Energy Stocks Took a Big Hit to Start 2026: Should Investors Worry?

Canadian crude prices on the US Gulf Coast plummeted, Bloomberg reported, after President Trump said Venezuela would give up 30 million-50 million barrels of oil to the US.

In three trading days on the Toronto Stock Exchange to start this week, Canada’s largest oilsands companies shed a combined $14 billion in stock market value, before notching a partial comeback Thursday — dropping the figure to about $8.

TORONTO, Jan 28 (Reuters) - Popular Canadian stock platforms experienced delays in processing trades on Thursday while some, including those operated by the big banks, suffered intermittent outages as they scrambled to accommodate a spike in volumes.

After three years of unusually high stock market gains, Wall Street equity analysts entered 2026 with record bullishness and no “sell” recommendations. Read more here.

President Donald Trump’s push to unlock Venezuelan crude is strengthening the political case for a proposed pipeline that would allow Canada to ship more oil to China and other Asian markets.